Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label EGFR. Show all posts
Showing posts with label EGFR. Show all posts
Saturday, March 17, 2012

Future Science - Abstract: EGFR/HER-targeted therapeutics in ovarian cancer

›
Blogger's Note : this is a subscription based ($$$) journal Future Science - Future Medicinal Chemistry - 4(4):447 - Summary Revie...
Thursday, February 09, 2012

abstract: (in mice) MEK1/2 Inhibitor Selumetinib (AZD6244) Inhibits Growth of Ovarian Clear Cell Carcinoma in a PEA-15–Dependent Manner in a Mouse Xenograft Model

›
Blogger's Note: in research (mice) Abstract Clear cell carcinoma (CCC) of the ovary tends to show resistance to standard chemothera...
Sunday, January 22, 2012

abstract: Recommendations on management of EGFR inhibitor-induced skin toxicity: A systematic review

›
"Due to the small number of randomized controlled trials conducted in the field of EGFR inhibitor-induced skin toxicity so far, it is...
Monday, June 13, 2011

HER3 - Turning off cancer's growth signals (pancreatic/ovarian)

›
Drugs that interfere with HER3’s better-known cousins, EGFR and HER2, have already proven effective in treating many types of cancer, and ...
Saturday, August 14, 2010

Expert Opinion on Medical Diagnostics - KRAS mutations - Summary

›
What the reader will gain: KRAS mutations in mCRC and NSCLC primary tumors predict resistance to EGFR-targeted therapy. In pancreatic cance...
Tuesday, June 22, 2010

Angiogenesis Inhibitors: Current Strategies and Future Prospects

›
Abstract/Full free access ( chapters ):  Introduction Inhibition of Angiogenesis for Anticancer Purposes   Process of Carcinogenesis an...